Reliq Health Technologies Inc.
RQHTF · OTC
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $9 | $1 | $1 | $0 |
| % Growth | 484.9% | 27.9% | 528.4% | – |
| Cost of Goods Sold | $3 | $7 | $8 | $6 |
| Gross Profit | $5 | -$6 | -$6 | -$6 |
| % Margin | 62% | -396.5% | -558.3% | -3,112.7% |
| R&D Expenses | $2 | $2 | $2 | $5 |
| G&A Expenses | $10 | $10 | $9 | $7 |
| SG&A Expenses | $11 | $11 | $9 | $8 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | -$6 | -$0 |
| Operating Expenses | $14 | $13 | $5 | $8 |
| Operating Income | -$8 | -$12 | -$11 | -$13 |
| % Margin | -97% | -795.6% | -982% | -7,413.2% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$8 | -$12 | -$11 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$12 | -$11 | -$13 |
| % Margin | -95.5% | -805.7% | -973.1% | -7,148.8% |
| EPS | -0.045 | -0.075 | -0.082 | -0.11 |
| % Growth | 40.2% | 9.4% | 25.2% | – |
| EPS Diluted | -0.045 | -0.075 | -0.082 | -0.11 |
| Weighted Avg Shares Out | 183 | 158 | 135 | 118 |
| Weighted Avg Shares Out Dil | 183 | 158 | 135 | 118 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$8 | -$12 | -$11 | -$13 |
| % Margin | -93.8% | -787% | -943% | -7,064.6% |